Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT03055364
In this study, the investigators propose to evaluate cognitive function and determine the feasibility of neurocognitive assessment using a select CogState test battery in patients with primary intracranial malignancies receiving photon- or proton-based cranial irradiation with curative intent. The investigators will use the CogState software to quantify changes in verbal learning, memory, and executive function over the initial months and years following radiation treatment. Cognitive changes and temporal patterns of function will be compared to baseline performance for each patient. Data regarding cognitive function, fatigue, quality of life, and standard patient reported outcomes will be collected to characterize the daily impact of treatment. In addition, observed outcomes will be correlated with dosimetry values, radiation dose volumes, and anatomic dose distribution.
Looking for future studies?
Notify Me4 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline, completion of treatment, 3 months, 6 months, 1 year and 2 years after radiotherapy
Using the CogState software
Mayo Clinic
Other
Observational Study Evaluating Neurocognitive Function in Patients With Primary CNS Malignancy Receiving Radiation Treatment to the Brain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06150547
CNS Malignancy, Central Nervous System Neoplasms
Rochester, Minnesota, United States
View Trial DetailsNCT01639911
Breast Diseases, Breast Neoplasms
Chicago, Illinois, United States
View Trial DetailsNCT03251989
Brain Diseases, Brain Neoplasms
Bethesda, Maryland, United States
View Trial DetailsNCT04743310
Astrocytoma, Brain Diseases
Los Angeles, California, United States
View Trial Details